TELA Bio is a commercial-stage medical technology company that develops reinforced tissue matrices for soft-tissue reconstruction, particularly hernia repair and plastic and reconstructive surgery. The company's primary product, OviTex, combines biologic material derived from sheep forestomach with interwoven polymer fibers in proprietary patterns, enabling rapid tissue integration while minimizing the inflammatory response associated with synthetic alternatives. TELA generates revenue through direct product sales to hospitals, ambulatory surgery centers, and healthcare systems, primarily in the U.S. market, with products sold at a significant discount to competing biologic and resorbable mesh options, supported by clinical evidence demonstrating safety and efficacy.